Latest News

Latest News

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer  Compounds with The Stock Day Podcast

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

adminFebruary 17, 20216 min read

For Immediate Release February 17, 2021 Phoenix, February 17th, 2021 (Newsfile Corp.) — The Stock Day Podcast welcomed  Sunshine Biopharma (SBFM)(“the Company”), a company engaged in the development of Adva-27a,…

SUNSHINE BIOPHARMA INITIATES COVID-19 TREATMENT MICE STUDY

SUNSHINE BIOPHARMA INITIATES COVID-19 TREATMENT MICE STUDY

adminFebruary 10, 20215 min read

For Immediate Release February 10, 2021 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”),  a pharmaceutical company focused on the research, development and commercialization of oncology…

SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY  OF GEORGIA FOR COVID-19 COMPOUNDS

SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF GEORGIA FOR COVID-19 COMPOUNDS

adminFebruary 4, 20215 min read

For Immediate Release February 4, 2021 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of oncology and…

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT  APPLICATION EXTENDING PROTECTION OF Adva-27a IN CANADA UNTIL 2033

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT APPLICATION EXTENDING PROTECTION OF Adva-27a IN CANADA UNTIL 2033

adminFebruary 2, 20215 min read

For Immediate Release February 2, 2021 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of oncology and…

SUNSHINE BIOPHARMA COMPLETES APPLICATION TO UPLIST TO OTCQB

SUNSHINE BIOPHARMA COMPLETES APPLICATION TO UPLIST TO OTCQB

adminJanuary 27, 20215 min read

For Immediate Release January 27, 2021 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of oncology…

SUNSHINE BIOPHARMA RECEIVES FOURTH TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT

SUNSHINE BIOPHARMA RECEIVES FOURTH TRANCHE FROM PREVIOUSLY ANNOUNCED $2,000,000 + FINANCING FOR CORONAVIRUS TREATMENT

adminJanuary 14, 20215 min read

For Immediate Release January 14, 2021 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”),  a pharmaceutical company focused on the research, development and commercialization of  oncology…

SUNSHINE BIOPHARMA’S CORONAVIRUS TREATMENT ANTICIPATED TO BE  EFFECTIVE AGAINST THE NEW VARIANT IDENTIFIED IN THE UK

SUNSHINE BIOPHARMA’S CORONAVIRUS TREATMENT ANTICIPATED TO BE EFFECTIVE AGAINST THE NEW VARIANT IDENTIFIED IN THE UK

adminDecember 22, 20205 min read

For Immediate Release December 22, 2020 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of  oncology and…

SUNSHINE BIOPHARMA ORDERS A NEW BATCH OF Adva-27a FOR TESTING ON TOPII  AMPLIFIED CANCERS

SUNSHINE BIOPHARMA ORDERS A NEW BATCH OF Adva-27a FOR TESTING ON TOPII AMPLIFIED CANCERS

adminDecember 8, 20204 min read

For Immediate Release December 8, 2020 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of oncology…

SUNSHINE BIOPHARMA PAYS OFF CONVERTIBLE NOTES IN CASH PREVENTING NEW SHARES FROM HITTING THE MARKET

SUNSHINE BIOPHARMA PAYS OFF CONVERTIBLE NOTES IN CASH PREVENTING NEW SHARES FROM HITTING THE MARKET

adminDecember 3, 20204 min read

For Immediate Release December 3, 2020 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”),a pharmaceutical company focused on the research, development and commercialization ofoncology and antiviral…